Pakistan

in page functions
[French]
Pakistan
Total population (2016) 192,825,612
Birth cohort (2016) 5,472,615
Surviving Infants (surviving to 1 year per year, 2016) 5,115,161
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 66/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 81/1000
World Bank Index, IDA (2012) 3.08
Co-financing status (2016) Preparatory transition
No. of districts/territories (2015) 147

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Pakistan

Type of support

Approvals

2001-2021 (US$)
(20 Dec 2016)

Commitments

2001-2021 (US$)
(20 Dec 2016)

Disbursements

2000-2016 (US$)
(20 Dec 2016)

% Disbursed

(20 Dec 2016)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Total $1,016,503,073 $1,135,159,573 $929,147,096
Civil Society Organisation support (CSO) $7,656,073 $7,656,073 $7,756,073 101%
Health system strengthening (HSS 1) $23,524,500 $23,524,500 $23,524,500 100%
Health system strengthening (HSS 2) $59,000,000 $84,000,000 $34,000,000 58%
HepB mono (NVS) $24,953,324 $24,953,324 $24,953,324 100%
Immunisation services support (ISS) $48,763,740 $48,763,740 $43,581,500 89%
Injection Safety Devices (NVS) $1,702,500 $3,100,000
Injection safety support (INS) $7,405,082 $7,405,082 $7,405,082 100%
IPV (NVS) $11,488,713 $11,488,713 $6,981,003 61%
Measles SIA (NVS) $10,029,548 $10,029,548 $10,029,548 100%
Measles SIA - Operational costs (OPC) $21,664,500 $21,664,500 $21,664,500 100%
Penta (NVS) $352,875,914 $377,433,914 $351,297,755 100%
Pneumo (NVS) $377,578,398 $425,412,898 $356,394,682 94%
Rotavirus (NVS) $22,856,500 $42,723,000
Tetra DTP-HepB (NVS) $31,387,734 $31,387,734 $31,387,734 100%
Vaccine Introduction Grant (VIG) $15,616,547 $15,616,547 $10,171,394 65%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Pakistan DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 75%
M:F sex ratio at birth (2016) 1.09
Household survey: DTP3 coverage for male (2012) 67.20%
Household survey: DTP3 coverage for female (2012) 63.10%
Household survey: Last DTP3 survey (2012) 61%
% districts achieving > 80% DTP3 coverage (2015) 59%
% districts achieving < 50% DTP3 coverage (2015) 14%
MCV WHO/UNICEF estimates (2015) 61%

Breakdown of support

Non-vaccine support Vaccine support
16% 84%
$148,103,048 $781,044,044

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Pakistan

13 January 2017

Punjab, Pakistan: first baby to be vaccinated with the rotavirus vaccine

Punjab pioneers protect children from deadly diarrhoea

Rotavirus vaccine introduction paves the way for national roll-out in Pakistan.

10 November 2016

Tanzania

Measles jab saves over 20 million young lives in 15 years, but hundreds of children still die of the disease every day

Measles outbreaks in numerous countries – caused by gaps in routine immunisation and in mass vaccination campaigns – continue to be a serious challenge.

24 October 2016

World Polio Day a

Polio portraits: voices from the frontline of eradication

Today marks World Polio Day, when the global community celebrates the immense progress and considers the work ahead to ensure no child suffers from polio ever again.

close icon

modal window here